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The interoceptive effects of alcohol are major determinants of addiction liability. Metabotropic glutamate (mGlu) receptors are widely
expressed in striatal circuits known to modulate drug-seeking. Given that the interoceptive effects of drugs can be important determi-
nants of abuse liability, we hypothesized that striatal mGlu receptors modulate the interoceptive effects of alcohol. Using drug discrim-
ination learning, rats were trained to discriminate alcohol (1 g/kg, i.g.) versus water. We found that systemic antagonism of metabotropic
glutamate subtype 5 (mGlu5) receptors [10 mg/kg 2-methyl-6-(phenylethynyl)pyridine (MPEP) and 3 mg/kg 3-((2-methyl-1,3-thiazol-4-
yl)ethynyl)pyridine], but not mGlu1 receptors ([0.3–3 mg/kg JNJ16259685) (3,4-dihydro-2H-pyrano[2,3]-quinolin-7-yl)(cis-4-
methoxycyclohexyl) methanone)], inhibited the discriminative stimulus effects of alcohol. Furthermore, mGlu5 receptor antagonism (10
mg/kg MPEP) significantly inhibited neuronal activity in the nucleus accumbens core as levels of the transcription factor c-Fos were
significantly reduced. Accordingly, targeted inhibition of mGlu5 receptors (20 g of MPEP) in the nucleus accumbens core blunted
the discriminative stimulus effects of alcohol (1 g/kg). Anatomical specificity was confirmed by the lack of effect of inhibition of
mGlu5 receptors (10 –30 g of MPEP) in the dorsomedial caudate–putamen and the similar cytological expression patterns and
relative density of mGlu5 receptors between the brain regions. Functional involvement of intra-accumbens mGlu5 receptors was confirmed as
activation of mGlu5 receptors [10 g of (RS)-2-amino-2-(2-chloro-5-hydroxyphenyl)acetic acid sodium salt] enhanced the discriminative stim-
ulus effects of a low alcohol dose (0.5 g/kg), and mGlu5 receptor inhibition (20 g of MPEP) prevented the agonist-induced enhancement. These
results show that mGlu5 receptor activity in the nucleus accumbens is required for the expression of the interoceptive effects of alcohol.
Introduction
Alcohol use is woven into the fabric of most societies with an
estimated global population of 2 billion who drink alcohol and
76.3 million who develop diagnosable alcohol use disorders
(World Health Organization, 2004). Prominent theories of ad-
diction argue that alcohol and other drugs of abuse usurp brain
reward systems, which include striatal circuits (Hyman et al.,
2006) that evolved to regulate natural reward and survival (Schultz,
2000). In addition to reward and reinforcement processes, the in-
teroceptive (subjective) effects of drugs represent a second major
controlling process that regulates drug-seeking behavior. For ex-
ample, the interoceptive effects of drugs can promote drug-seeking
(Wise et al., 2008) and can interact with or supplement positive
reinforcing effects by providing drug-specific qualitative and quan-
titative feedback to the organism (Stolerman, 1992). Thus, delineat-
ing the neural mechanisms of the interoceptive effects of alcohol and
other drugs is critical to understanding how these substances gain
control over behavioral functions in addiction.
For decades, the drug discrimination procedure has been used
in both humans and animals as a compelling measure of the
interoceptive effects of drugs (Kelly et al., 1997); however, the
mechanisms that regulate how the brain perceives alcohol re-
main to be fully characterized. Although there is a well estab-
lished role for ionotropic glutamate receptors and related
brain circuitry in modulating the interoceptive effects of alcohol
(Grant et al., 1991; Hodge and Cox, 1998), the role of metabo-
tropic glutamate (mGlu) receptor activity in striatal circuits is
unknown. This point is especially relevant given that mGlu
(mGlu1, mGlu5, and mGlu2/3) receptors regulate alcohol self-
administration and relapse-like behavior (Bäckström et al., 2004;
Bäckström and Hyytiä, 2005; Cowen et al., 2005; Schroeder et al.,
2005, 2008; Hodge et al., 2006; Lominac et al., 2006; Rodd et al.,
2006; Cowen et al., 2007; Besheer et al., 2008b). Furthermore,
mGlu receptor activity in the nucleus accumbens regulates co-
caine and heroin-seeking behaviors (Bossert et al., 2006; Peters
and Kalivas, 2006; Kumaresan et al., 2009) and is required for
drug-induced changes in synaptic plasticity (Robbe et al., 2003).
As such, mGlu receptors are rapidly emerging as potential thera-
peutic targets for alcoholism and other addictions (Heilig and
Egli, 2006).
Given that information about the interoceptive effects of a
drug may interact with its positive reinforcing properties and that
mGlu receptors are densely expressed within striatal regions
known to modulate alcohol-seeking behavior (Ferraguti and
Shigemoto, 2006), we hypothesized that striatal mGlu receptors
regulate the discriminative stimulus effects of alcohol. To address
this hypothesis, we used a well characterized drug discrimination
procedure to train rats to discriminate the interoceptive effects of
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a moderate dose of alcohol (1 g/kg, i.g.) from water (intragastric
gavage). Preliminary work has shown that systemic antagonism
of mGlu5 receptors inhibits the GABAergic component of the
discriminative stimulus effects of alcohol (Besheer and Hodge,
2005). To extend this work, we first asked whether inhibition of
glutamate neurotransmission by systemic pharmacological block-
ade of group I mGlu receptors produces discriminative stimulus
effects that generalize to alcohol. Next, we examined whether mGlu
receptors modulate the discriminative stimulus effects of alcohol.
Using immunohistochemical techniques to evaluate c-Fos im-
munoreactivity (IR), we next determined whether mGlu5 recep-
tor inhibition is associated with changes in neuronal activity in
the striatum. Finally, guided by the anatomical and pharmaco-
logical specificity of the results, we sought to determine whether
mGlu5 receptors in the nucleus accumbens core functionally reg-
ulate the discriminative stimulus effects of alcohol.
Materials and Methods
Animals
For the discrimination training experiments, male Long–Evans rats
(Harlan Sprague Dawley) weighing 150 –200 g on arrival to the colony
were individually housed in Plexiglas cages. Rats were handled and
weighed daily for 2 weeks before lever press training began. Rats were fed
16 g of food daily for the duration of the study such that weights were
maintained at 325 g. Water was available continuously in the home
cage. The colony room was maintained on a 12 h light/dark cycle, and
experiments were conducted during the light portion of the cycle. Ani-
mals were under continuous care and monitoring by veterinary staff
from the Division of Laboratory Animal Medicine at University of North
Carolina-Chapel Hill. All procedures were also performed in accordance
with the National Institutes of Health Guide to Care and Use of Laboratory
Animals and institutional guidelines.
Apparatus
Operant chambers (Med Associates) measuring 31  32  24 cm were
located within sound-attenuating cubicles and equipped with an exhaust
fan that provided ventilation and masked external sounds. Two response
levers were located on the right wall of each chamber. Responses on the
levers activated a liquid dipper centered between the levers that presented
a 10% sucrose (w/v) solution in a 0.1 ml dipper cup for 4 s during each
operation. A stimulus light was located above each response lever and
was activated each time a reinforcer was delivered. The chambers were
illuminated by an 8 W light and were interfaced (Med Associates) to a
computer programmed to control sessions and record data.
Alcohol discrimination training and testing procedures
Rats were trained to lever press on a fixed-ratio 1 (FR1) schedule of
reinforcement. The presentation of the right and left lever was alternated
each day, and the schedule of reinforcement was gradually increased to
FR10. Discrimination training began once responding on the FR10
schedule was stable (10% daily variation in total number of responses).
Discrimination training. Training sessions were conducted 5 d/week
(Monday through Friday) during which alcohol (1 g/kg) or water was
administered by intragastric gavage before the start of the sessions. Im-
mediately after the alcohol or water administration, the rats were placed
in the chambers, and, after a 10 min delay, the house light was illumi-
nated and both levers were introduced into the chamber signaling the
beginning of the 15 min session. The lever associated with alcohol or
water administration was randomly assigned and counterbalanced
across animals. After alcohol administration, completion of 10 responses
on the alcohol-appropriate lever resulted in the presentation of the su-
crose solution. Similarly, after water administration, completion of 10
responses on the water-appropriate lever resulted in sucrose delivery.
During both alcohol and water sessions, responses on the inappropriate
lever were recorded but produced no programmed consequences. Water
and alcohol training days varied on a double alternation schedule (W, W,
A, A . . .). The training sessions continued until the percentage of
alcohol- and water-appropriate lever press responses emitted before the
first reinforcer and during the entire session was 80% for 8 of 10 con-
secutive days. Once these criteria were met, testing began.
Testing. Test sessions were identical to the training sessions except that
they were 2 min in duration (after the 10 min delay), and completion of
an FR10 on either lever resulted in sucrose delivery. Reinforcement was
delivered during test sessions to assess the possible effects of test treat-
ments on overall response rates. These test sessions were interspersed
with training sessions only if performance during three of the previous
four training sessions met the accuracy criteria. For all rats, an alcohol
substitution curve was determined before testing of the mGlu receptor
compounds to ensure adequate alcohol stimulus control. Cumulative
dosing procedures (Hiltunen and Järbe, 1989) were used for all the test-
ing sessions, with the exception of the microinjection studies. For exam-
ple, to determine a cumulative alcohol dose curve (0.1, 0.3, 1.0, and 1.7
g/kg), rats initially received 0.1 g/kg alcohol and were placed in the cham-
ber for a testing session. At the conclusion of the session, the rats received
a subsequent alcohol administration of 0.2 g/kg and another test session.
This procedure was repeated with two subsequent administrations of 0.7
g/kg alcohol, which are additive to produce the stated dose range. Thus,
testing of the entire dose curve was completed in 48 min. Testing
occurred no more than twice per week.
Surgery and microinjection procedures
Surgery. Discrimination-trained rats were anesthetized with an isoflu-
rane/oxygen combination, and 26 gauge guide cannulae (Plastics One)
were implanted bilaterally to terminate 2 mm above the nucleus accum-
bens core or the dorsomedial caudate–putamen. The coordinates for the
nucleus accumbens and caudate were anteroposterior (AP) 1.7, me-
diolateral (ML) 1.5 mm, dorsoventral (DV) 5.5 mm; and AP 1.7
mm, ML 1.5 mm, DV 2.4 mm, respectively (Paxinos and Watson,
1998). All rats were allowed to recover for at least 1 week before resuming
alcohol discrimination training.
Drug administration. Injections were made with Hamilton syringes
connected to 33 gauge injectors (Plastics One) that extended 2 mm below
the guide cannulae. A pump (model 22; Harvard Apparatus) was used to
deliver a volume of 0.5 l into each side over 1 min; the injectors were left
in place for another 1.5 min after the injections to allow for diffusion.
Rats were then administered a single alcohol dose and placed in the
chambers for a test session.
Cannulae verification. Once the experiment was complete, rats were
deeply anesthetized with pentobarbital and perfused transcardially with
0.1 M PBS, followed by 4% formaldehyde, pH 7.4. Brains were extracted,
sliced into 40 m coronal sections, and stained with cresyl violet. Can-
nulae placement was verified using an Olympus CX41 light microscope
(Olympus America) and only the data from rats with cannulae deter-
mined to be in the target brain regions were used in the analyses. For the
2-methyl-6-(phenylethynyl)-pyridine (MPEP) study (experiment 3),
one rat from each of the groups (nucleus accumbens and dorsomedial
caudate) had an incorrect placement (data not shown) and is not in-
cluded in any of the data. Anatomical location is shown in Figure 4, a and
b. For the (RS)-2-amino-2-(2-chloro-5-hydroxyphenyl)acetic acid so-
dium salt (CHPG)/MPEP study (experiment 5), two rats had incorrect
placements, and one rat had an infection. Data from these rats were not
included in the analyses and are not illustrated in Figure 5c.
Immunohistochemistry procedures
c-Fos. Free-floating sections were blocked in PBS/0.1% Triton X-100/
10% goat serum and then incubated in PBS/0.1% Triton X-100/3% goat
serum and rabbit anti-c-Fos antibody (1:20,000 dilution; Calbiochem)
for 48 h at 4°C with agitation. Western blot analysis from previous char-
acterization indicated that the antibody recognizes 55 kDa c-Fos and 62
kDa c-Fos proteins and does not cross-react with the 39 kDa Jun proteins
(the technical informationof the manufacturer). Sections were then
washed in PBS, incubated for 1 h in a solution of biotinylated secondary
anti-rabbit antibody, and then rinsed in PBS. Sections were next pro-
cessed with avidin– biotin complex (Vector ABC kit; Vector Laborato-
ries), and Fos-IR was visualized using a diaminobenzidine solution
(Polysciences) containing 0.006% hydrogen peroxide, 0.005% cobalt,
and 0.0075% nickel. For consistency of staining across subjects, brain
tissue was processed simultaneously.
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mGlu5 receptor. Endogenous peroxidase was blocked by incubating
the free-floating sections in 1% hydrogen peroxide for 5 min, followed by
citra buffer antigen retrieval performed at 70°C for 30 min (Antigen
Retrieval Citra; BioGenex). Sections were blocked in PBS/0.1%Triton
X-100/10% goat serum for 1 h and then incubated in PBS/0.1% Triton
X-100/3% goat serum and rabbit anti-mGlu5 receptor (1:3000; Upstate
Biotechnology). This antibody stains a single band of 125 kDa molecular
weight on Western blot (the technical information of the manufacturer).
Sections were then incubated in secondary antibody for 1 h using the
Dako EnVision kit. Immunoreactivity was detected with nickel-
enhanced diaminobenzidine (Dako EnVision Kit) as a chromagen. Sec-
tions were then counterstained with toluidine blue, mounted, dried, and
coverslipped with Cytoseal. For consistency of staining across subjects,
brain tissue was processed simultaneously.
Immunohistochemical quantification
c-Fos and mGlu5 receptor immunoreactivity was visualized using an
Olympus CX41 light microscope (Olympus America). Images were ac-
quired using a digital camera (Regita model; QImaging) interfaced to a
desktop computer (Dell Computer Company). Image analysis software
(Bioquant Nova Advanced Image Analysis; R & M Biometric) was used to
quantify immunoreactivity. The microscope, camera, and software were
background corrected and normalized to preset light levels to ensure
fidelity of data acquisition. For Fos immunoreactivity, cell count mea-
surements were calculated from a circumscribed field (e.g., brain region),
divided by the area of the region, and expressed as Fos-positive cells per
square millimeter. mGlu5 receptor immunoreactivity was quantified as
pixel density per square millimeter. Analysis was conducted by a researcher
blind to treatment conditions. Data were acquired from a minimum of
three sections per brain region per animal for the Fos-immunoreactivity
analyses and two sections per brain region per animal for the mGlu5
receptor immunoreactivity analyses; the data were then averaged to ob-
tain a single value per subject. The brain regions examined for the Fos
analyses were the nucleus accumbens (shell and core) and the caudate–
putamen (dorsomedial and ventral), and for the mGlu5 receptor analyses
the nucleus accumbens (core) and the caudate–putamen (dorsomedial)
were all analyzed at AP 1.7–1.0 mm (see Fig. 3a).
Western blot analysis
Rats were anesthetized using isoflurane and decapitated. Brains were
rapidly removed and frozen in isopentane at 40°C and stored at 80°C.
Frozen brains were sectioned coronally into 1 mm sections using a cry-
ostat at 15°C (Leica), and 1.25-mm-diameter punches were taken from
the nucleus accumbens core and dorsomedial caudate–putamen using a
punch tool (Stoelting) and submerged in buffer (100 l: 8 mmol/L
NaH2PO4 monobasic, 0.5 mmol/L NaH2PO4 dibasic, 147 mmol/L NaCl,
1:100 protease, and phosphatase 1 and 2 inhibitor cocktails). Tissue was
homogenized via sonication (Branson Sonifier), and protein concentra-
tion was measured using a calorimetric assay kit (Pierce). Protein (10 g)
was diluted 4:1 with lithium dodecyl sulfate sample buffer (40 –70%
glycerol), 10:1 with sample reducing agent, vortexed, loaded onto a Nu-
Page 4–12% Bis-Tris polyacrylamide gel (Invitrogen) for gel electrophoresis
separation, and transferred to nitrocellulose membrane using an iBlot dry
blotting system (Invitrogen). Membranes were blocked with 3% albumin
bovine serum (Sigma) before being incubated with primary antibodies [rab-
bit anti-mGlu5 receptor (1:1000; Upstate Biotechnology) in blocking solu-
tion 4°C overnight and -actin (mouse monoclonal, 1:5000; Sigma) in
blocking solution 1 h at room temperature] and washed before incubation
with secondary antibodies (HRP-conjugated goat anti-rabbit and goat anti-
mouse, 1:10,000; Jackson ImmunoResearch). Membranes were then visual-
ized using enhanced chemiluminescence substrate (Pierce), and bands were
quantified using optical density measurements (NIH/Scion Image). Data
were converted to percentage of -actin for each blot.
Experiment 1: effects of mGlu receptor compounds alone and on
the discriminative stimulus effects of alcohol
Systemic antagonist substitution. To determine whether the mGlu receptor
compounds produced alcohol-like interoceptive effects, cumulative dose
ranges of the mGlu1 receptor antagonist (3,4-dihydro-2H-pyrano[2,3]-
quinolin-7-yl)(cis-4-methoxycyclohexyl) methanone (JNJ16259685)
(0.3–10 mg/kg, i.p.) and the mGlu5 receptor antagonist MPEP (1–30
mg/kg, i.p.) were tested; water/alcohol administration was withheld
during these tests.
Systemic mGlu receptor modulation of the discriminative stimulus effects
of alcohol. To determine whether the mGlu receptor compounds altered
the interoceptive effects of alcohol, the compounds [JNJ16259685, 0 –3
mg/kg, i.p.; MPEP, 0 –10 mg/kg, i.p.; 3-((2-methyl-1,3-thiazol-4-
yl)ethynyl)pyridine (MTEP), 0 –3 mg/kg, i.p.] were administered 10 min
before the first alcohol dose of the cumulative alcohol substitution test.
The antagonists tested demonstrate peak and stable receptor occupancy
for at least the first hour after administration (Anderson et al., 2003;
Lavreysen et al., 2004) and, as such, appear suitable for testing using the
48 min cumulative dosing procedures. Dose order testing of the mGlu
receptor compounds was randomized.
Experiment 2: effects of mGlu5 receptor antagonism on striatal
c-Fos immunoreactivity
Male Long–Evans rats (mean  SEM, 358.5  5.7 g; Harlan Sprague
Dawley) were habituated to handling for 5 d. A day before the test, rats
were administered saline (intraperitoneally). On the test day, rats were
administered saline (intraperitoneally) or MPEP (10 mg/kg, i.p.). Ap-
proximately 110 min after the saline or MPEP administration, rats were
deeply anesthetized with pentobarbital and perfused with 0.1 M PBS,
followed by 4% paraformaldehyde, 4°C, pH 7.4. The brains were re-
moved from the skull and placed in the same fixative solution for 24 h
before being washed with PBS and sliced coronally on a vibratome into
40 m sections. Tissue was stored (20°C) in cryoprotectant until im-
munohistochemistry processing.
Experiment 3: effects of intrastriatal mGlu5 receptor antagonism
on the discriminative stimulus effects of alcohol
MPEP was microinfused into the nucleus accumbens (0 –20 g/0.5 l
per side) or the dorsomedial caudate (0 – 30 g/0.5 l per side). After the
diffusion period, rats received a single alcohol dose (1 g/kg, i.g.) and were
placed in the chamber for a test session. Test sessions were identical in
parameters to the cumulative dosing test sessions, with the exception that
rats experienced a single test. A single MPEP and alcohol dose was tested
in random order during each session.
Experiment 4: assessment of mGlu5 receptor expression in the
nucleus accumbens and dorsomedial caudate
To establish whether mGlu5 receptors are similarly expressed in the nu-
cleus accumbens and the dorsomedial caudate, brain tissue from the two
regions was evaluated using mGlu5 receptor immunoreactivity and
Western blot analysis. Tissue from the saline-treated rats in the c-Fos
mapping study was used for analysis of mGlu5 receptor immunoreactiv-
ity. Tissue from male Long–Evans rats (mean  SEM, 360  4.6 g; n  4;
Harlan Sprague Dawley) was used for the analysis of mGlu5 receptor
protein expression using Western blot analysis.
Experiment 5: effects of intra-accumbens mGlu5 receptor
activation on the discriminative stimulus effects of alcohol
The mGlu5 receptor agonist CHPG was microinfused into the nucleus
accumbens (0 or 10 g/0.5 l per side). After the 1.5 min diffusion
period, rats received a single alcohol dose (0.5 g/kg, i.g.) and were placed
in the chamber for a test session. To assess whether mGlu5 receptor
antagonism could inhibit the mGlu5 receptor agonist-induced effects,
MPEP was first microinfused into the nucleus accumbens (10 g/0.5 l
per side). Five min after the end of the diffusion period, CHPG (10 g/0.5
l per side) was microinfused into the nucleus accumbens. After the
diffusion period, rats received a single alcohol dose (0.5 g/kg, i.g.) and
were placed in the chamber for a test session. Rats received another test in
which CHPG (0 or 10 g/0.5 l per side) was microinfused into the
nucleus accumbens core before a low alcohol dose (0.3 g/kg, i.g.).
Drugs
For intragastric gavage administration, ethanol (95% w/v) was diluted in
distilled water to a concentration of 20% (v/v) and administered in var-
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ious volumes to obtain cumulative doses of 0.1, 0.3, 1.0, and 1.7 g/kg. A
corresponding volume of water to the 1 g/kg alcohol training dose was
used for water intragastric gavage administration. MPEP (Sigma-
Aldrich) was dissolved in saline (vehicle) for systemic administration and
in artificial CSF (aCSF) for microinfusions. MTEP (Ascent Scientific)
was dissolved in saline (vehicle). JNJ16259685 (Tocris Biosciences) was
suspended in 0.1% carboxymethocellulose (vehicle). All compounds
were injected intraperitoneally at a volume of 1 ml/kg. CHPG (Ascent
Scientific) was dissolved in aCSF for microinfusions.
MPEP is a systemically active noncompetitive mGlu5 receptor antag-
onist that shows at least 1000-fold greater specificity for mGlu5 than
mGlu1 receptors (Gasparini et al., 1999). JNJ16259685 is a systemically
active potent noncompetitive mGlu1 receptor antagonist that displays
1000-fold selectivity over mGlu5 receptors in a Ca2 mobilization assay
(Lavreysen et al., 2004). MPEP and JNJ16259685 also display no agonist,
antagonist, or allosteric activity at mGlu2, mGlu3, or mGlu6 receptors
(Gasparini et al., 1999; Lavreysen et al., 2004), and importantly mGlu5
receptor-deficient mice show no binding of MPEP (Anderson et al.,
2003). However, Mathiesen et al. (2003) has shown agonist-like activity
of MPEP at mGlu4 receptors in BHK cells, and
MPEP has also been shown to blunt NMDA-
evoked currents (O’Leary et al., 2000). MTEP is
a potent systemically active noncompetitive
mGlu5 receptor antagonist (Anderson et al.,
2003; Cosford et al., 2003); affinities (Ki values)
of MPEP and MTEP at rat mGlu5 receptors are
12 and 16 nM, respectively (Cosford et al.,
2003). CHPG selectively activates mGlu5 re-
ceptors, not mGlu1 receptors, but has been
shown to potentiate NMDA function in vitro
(Doherty et al., 1997).
Data analysis
For the behavioral experiments, response ac-
curacy was expressed as the percentage of
alcohol-appropriate lever presses during de-
livery of the first reinforcer. Response rate (re-
sponses per minute) was analyzed for the entire
session and provided an index of locomotor
ability. Complete expression of the discrimina-
tive stimulus effects of alcohol (i.e., full substi-
tution) was defined as 80% choice of the
alcohol lever on completion of the first FR10
during test sessions. If an animal did not
complete an FR10 during these test sessions,
then data from that animal was not included
in the response accuracy analysis but were
included in the response rate analysis. One-
or two-way repeated measures ANOVA were
used to analyze response accuracy and re-
sponse rate data. Response accuracy data
were subjected to arcsine transformation
to normalize the distribution of the percent-
age scores (Stolerman and Olufsen, 2000).
Fos-IR, mGlu5 receptor expression, and IR
were analyzed using one-way ANOVA.
Tukey’s post hoc analyses were used to ex-
plore significant interactions. Significance




To ensure adequate alcohol stimulus con-
trol, a cumulative alcohol substitution
curve was determined for all rats before
testing of the mGlu receptor com-
pounds began. Alcohol-appropriate re-
sponding increased as a function of al-
cohol test dose (Fig. 1a) (F(3,111)  71.10, p  0.001), with 1.7
g/kg resulting in full substitution (80%) for the alcohol
training dose (i.e., produced discriminative stimulus effects
similar to the training dose). The 1.0 g/kg alcohol dose (i.e.,
training dose), which generally produces 90% alcohol-
appropriate responding during regular training sessions (Fig.
1a, left of axis break), tends to produce 60% alcohol-
appropriate responding under the cumulative dosing proce-
dure (Hodge et al., 2001b). A slight decrease in response rate
was observed at the highest alcohol dose (1.7 g/kg; F(3,111) 
4.63, p  0.004) (Fig. 1b).
Experiment 1: effects of mGlu receptor compounds alone and
on the discriminative stimulus effects of alcohol
We first asked whether inhibition of glutamate neurotransmis-
sion by pharmacological blockade of group I mGlu receptors
Figure 1. mGlu receptor compounds do not produce alcohol-like interoceptive effects when tested alone in the absence of
alcohol. a, Before testing of the mGlu receptor compounds, alcohol stimulus control was confirmed in all rats by determination of
an alcohol substitution curve. The percentage of alcohol-appropriate lever responses (a) and response rate (b) during the water
(W) and alcohol (A) training session that preceded testing of the cumulative alcohol curve are shown to the left of the axis break
(not included in the analyses). Dose-dependent substitution for the 1 g/kg alcohol training dose was observed, indicating that the
procedures established reliable stimulus control; b, a reduction in response rate was observed at the highest alcohol dose (1.7
g/kg). c, Antagonism of mGlu1 (JNJ16259685, intraperitoneally; n  10) or mGlu5 (MPEP, intraperitoneally; n  10) (e) receptors
did not produce alcohol-like properties, although reductions in response rate (d, f ) indicate that the compounds were behaviorally
active. Horizontal dashed line (80%) represents full expression of the discriminative stimulus effects of alcohol. *p  0.05,
significant difference from 0.1 g/kg alcohol (Tukey’s test). Values on graphs represent mean  SEM.
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(i.e., mGlu1 and mGlu5 receptor antago-
nists) produces discriminative stimulus
effects that generalize to alcohol. The
group I mGlu receptor antagonists did
not produce alcohol-like properties
(i.e., 40% alcohol-appropriate re-
sponding) (Fig. 1c,e); however, signifi-
cant reductions in response rate (Fig. 1d:
JNJ16259685, F(3,27)  8.44, p  0.001;
Fig. 1f: MPEP, F(3,29)  3.83, p  0.02)
were observed, indicating that the com-
pounds were biologically active at the
tested doses and pretreatment time
intervals.
To test the extent to which mGlu
receptors modulate the discriminative
stimulus effects of alcohol, rats received
pretreatment administration of the mGlu
receptor compounds before alcohol (cumu-
lative doses, 0.1–1.7 g/kg, i.g.) administra-
tion. The mGlu1 receptor antagonist
JNJ16259685 did not alter the discrimina-
tive stimulus effects of alcohol (Fig. 2a)
but produced motor reductions as indi-
cated by a significant main effect of
JNJ16259685 dose (F(3,27)  3.63, p 
0.03) (Fig. 2b), again indicating that the
compound was biologically active at the
tested doses and pretreatment time inter-
val. In contrast, mGlu5 receptor antago-
nism by MPEP blocked the discriminative
stimulus effects of 1 and 1.7 g/kg alcohol
(Fig. 2c) (alcohol dose, F(3,30)  27.91, p 
0.001; MPEP dose, F(3,30)  5.66, p  0.003;
interaction, F(9,90)  1.97, p  0.05), re-
sulting in alcohol-appropriate responding
at a level that would be expected by chance
alone on a two-lever task (i.e., 50%). A
significant response rate reduction was
observed by MPEP pretreatment as in-
dicated by a significant main effect of
MPEP dose (F(3,30)  4.77, p  0.008)
and a significant interaction (F(9,90) 
2.89, p  0.005); however, the reduction
in the discriminative stimulus effects of
alcohol occurred at a dose that did not produce nonspecific
motor reductions (Fig. 2d). To confirm the specificity of
mGlu5 receptor function in altering the discriminative stimulus
effects of alcohol, we examined another mGlu5 receptor antagonist,
MTEP. MTEP pretreatment inhibited the discriminative stimulus
effects of 1.7 g/kg alcohol to an equal degree as MPEP by a dose of 3
mg/kg (Fig. 2e) (alcohol dose, F(3,24)  10.14, p  0.001; MTEP
dose, F(2,16)  4.09, p  0.04; interaction, F(6,48)  2.61, p  0.03).
MTEP pretreatment resulted in nonspecific changes (both in-
creases and decreases) in response rates as indicated by a sig-
nificant main effect of MTEP dose (F(2,16)  49.1, p  0.02)
and a significant interaction (F(6,48)  6.81, p  0.001) (Fig.
2f ); however, the reduction in the discriminative stimulus ef-
fects of alcohol was not accompanied by a change in response
rate. Given that the results from the MTEP assessment con-
firmed that the inhibition of the discriminative stimulus ef-
fects of alcohol were specific to mGlu5 receptor antagonism
and not attributable to any possible off-target effects of MPEP,
MPEP was used as the mGlu5 receptor antagonist for the re-
mainder of the study.
Experiment 2: effects of mGlu5
receptor antagonism on striatal
c-Fos immunoreactivity
To determine whether mGlu5 receptor inhibition is associated with
changes in neuronal activity in the striatum, we examined Fos-IR in
subnuclei of the striatum (Fig. 3a) after systemic administration of
the mGlu5 receptor antagonist MPEP. Results showed that MPEP
produced a significant (2.7-fold) reduction in Fos-IR in the nucleus
accumbens core (Fig. 3b–d) (F(1,7)  25.09, p  0.002). In contrast,
neural activity in the nucleus accumbens shell and dorsomedial and
lateral caudate–putamen was not altered by mGlu5 inhibition (Fig.
3b, e, f). These data suggest that systemic inhibition of mGlu5 recep-
tors is associated with inhibition of neural activity in the core of the
nucleus accumbens.
Figure 2. Antagonism of mGlu5 receptors reduces the interoceptive effects of alcohol. Antagonism of mGlu1 receptors by
JNJ16259685 (JNJ; administered intraperitoneally; n  10) did not alter the discriminative stimulus effects of alcohol (a) but
produced an overall reduction in response rate (b). c, Antagonism of mGlu5 receptors by MPEP (10 mg/kg, i.p.; n  11) prevented
full expression of the discriminative stimulus effects of alcohol, at doses that did not alter response rate (d). Antagonism of mGlu5
receptors by MTEP (intraperitoneally; n  8) also prevented the full expression of the discriminative stimulus effects of alcohol (e)
and produced both decreases and increases in response rate (f ). Horizontal dashed line (80%) represents full expression of the
discriminative stimulus effects of alcohol. * signifies significant difference from vehicle (Tukey’s test, p  0.05). Values on graphs
represent mean  SEM.
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Experiments 3 and 4: effects of intrastriatal mGlu5 receptor
antagonism on the discriminative stimulus effects of alcohol
Guided by the anatomical specificity of the c-Fos immunore-
activity results, we sought to determine whether mGlu5 recep-
tors in the nucleus accumbens core functionally regulate the
discriminative stimulus effects of alcohol. Microinfusion of
the mGlu5 receptor antagonist MPEP in the nucleus accum-
bens core blocked the discriminative stimulus effects of alco-
hol (1 g/kg, i.g.; F(2,12)  6.82, p  0.01) (Fig. 4a), establishing
a mechanistic role for intra-accumbens mGlu5 receptor activ-
ity. Response rate was unaffected by MPEP administration
because neither dose differed from vehicle (Fig. 4a). To assess
the functional and neuroanatomical specificity of mGlu5 re-
ceptor activity in the nucleus accumbens, we next evaluated the
effects of MPEP in the dorsomedial caudate–putamen. In this
brain region, mGlu5 antagonism did not alter the discriminative
stimulus effects of alcohol even when a higher MPEP dose range
was tested (Fig. 4b) (F(3,20)  2.07, p  0.14), and response rate
was unaffected by MPEP pretreatment (Fig. 4b). To verify sensi-
tivity and function of mGlu5 receptors in the dorsomedial cau-
date–putamen, we tested a higher alcohol dose (1.7 g/kg, i.g.) in
combination with MPEP (30 g) and found only nonspecific
reductions in motor activity [i.e., response rate (responses per
minute) reduced from 64.1  4.9 to 55.5  5.4; t(7)  2.50, p 
0.04], with no effect on the discriminative stimulus effects of
alcohol.
Examination of mGlu5 receptor immunoreactivity (Fig. 4c)
and protein expression (Fig. 4d) confirmed that differential brain
region involvement in the discriminative stimulus effects of alco-
hol was not attributable to differences in cytological expression
pattern, or relative density, of mGlu5 receptors in the nucleus
accumbens core or the dorsomedial caudate–putamen.
Experiment 5: effects of intra-accumbens mGlu5 receptor
activation on the discriminative stimulus effects of alcohol
To further establish functional involvement of mGlu5 receptor
activity in the discriminative stimulus effects of alcohol, we next
examined whether activation of mGlu5 receptors could potenti-
ate the discriminative stimulus effects of a low alcohol dose (0.5
g/kg). A one-way repeated measures ANOVA showed that micro-
infusion of the mGlu5 receptor agonist CHPG in the nucleus
accumbens core potentiated the discriminative stimulus effects
of alcohol (0.5 g/kg, i.g.) (Fig. 5a), and antagonism of mGlu5
receptors by intra-accumbens MPEP pretreatment prevented the
agonist-induced potentiation of the discriminative stimulus ef-
fects of alcohol (0.5 g/kg, i.g.; F(2,14)  8.65, p  0.004) (Fig. 5a).
Response rate was unaffected by CHPG or MPEP pretreatment
(Fig. 5b). Interestingly, the two rats that were excluded from the
study as a result of incorrect cannulae placement showed no
change in behavior after CHPG treatment or combined MPEP
and CHPG treatment. Furthermore, there was a trend for a
CHPG (10 g)-induced enhancement of a low alcohol dose (0.3
g/kg, i.g.; alcohol-appropriate responses: aCSF, 26.7  11.9%;
CHPG, 37.7  18.5%). This finding also suggests that mGlu5
receptor activation at this agonist dose likely does not produce
alcohol-like properties alone.
Discussion
These results show that mGlu5 receptor activity in the nucleus
accumbens is required for the expression of the interoceptive
effects of alcohol using drug discrimination procedures. Specifi-
cally, we report that systemic pharmacological antagonism of
mGlu5, but not mGlu1, receptors blocked the discriminative
stimulus effects produced by alcohol (1 g/kg, i.g.). Systemic ad-
ministration of the mGlu5 receptor antagonist MPEP was found
to dramatically inhibit neural activity in the nucleus accumbens
core as indexed by c-Fos immunoreactivity. The anatomical spec-
ificity of this finding led us to target mGlu5 receptors in the
nucleus accumbens core as a potential anatomical substrate of the
interoceptive effects of alcohol. Accordingly, microinjection of
the mGlu5 receptor antagonist MPEP in the nucleus accumbens
core blocked the discriminative stimulus effects of alcohol with
an order of potency 160-fold greater than that observed after
systemic administration of the compound. Moreover, pharma-
cological activation of mGlu5 receptors in the nucleus accum-
bens core enhanced the discriminative stimulus effects of a low
alcohol dose (0.5 g/kg), an effect that was blocked by intra-
accumbens mGlu5 receptor inhibition, further confirming func-
tional involvement of this receptor system in the expression of the
interoceptive effects of alcohol.
Figure 3. Neural activity in the nucleus accumbens core is significantly reduced by mGlu5
receptor antagonism. a, Illustration of quantified areas. b, Antagonism of mGlu5 receptors by
MPEP (10 mg/kg, i.p.) significantly reduced the number of Fos-positive cells (n  5 per group)
in the nucleus accumbens core. The other surveyed regions were not altered by MPEP pretreat-
ment. c–f, Representative photomicrographs (10) of Fos-IR in the nucleus accumbens [Acb
(core)] and the dorsomedial caudate–putamen [CPu (DM)] after vehicle or MPEP. Scale bars, 50
m. *p  0.05, significant difference from vehicle (Tukey’s test). Values on graphs represent
mean  SEM.
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The group I family (mGlu1 and mGlu5) of mGlu receptors
has become a viable target for therapeutic interventions for the
treatment of various CNS diseases, including drug abuse. Antag-
onism of group I receptors, which are predominantly postsynap-
tic (Shigemoto et al., 1997), has been shown to modulate cocaine,
nicotine, and alcohol self-administration and drug-seeking be-
havior in reinstatement models (Paterson et al., 2003; Tessari et
al., 2004; Bespalov et al., 2005; Cowen et al., 2005; Schroeder et al.,
2005, 2008; Hodge et al., 2006). Thus, it is critical to evaluate
whether the interoceptive effects of alcohol are modulated by
these receptors as a possible mechanism(s) that could promote
alcohol-seeking and/or alter alcohol self-administration. Results
from this study show that systemic administration of the mGlu5
receptor antagonists MPEP or MTEP each inhibited the full ex-
pression of the interoceptive effects of alcohol. These findings
extend previous work from our laboratory that used a single sys-
temically administered high dose of MPEP (Besheer and Hodge,
2005) by showing that inhibition of the interoceptive effects of
alcohol is dose sensitive, specific to the mGlu5 receptor as con-
firmed by testing MTEP, and selective to the mGlu5 receptor as
determined by the evaluation of mGlu1 receptors. Given that mGlu5
receptor antagonism has been shown to reduce alcohol self-
administration (Bäckström et al., 2004; Cowen et al., 2005; Schroe-
der et al., 2005; Hodge et al., 2006), this raises the possibility that
these reductions may be related to an alteration of the interoceptive
effects of the self-administered/consumed alcohol. It will be interest-
ing to directly address this possibility in future experiments. In-
deed, mGlu5 receptor antagonism has been shown to blunt the
discriminative stimulus effects of self-administered alcohol in
discrimination-trained rats (Besheer et al., 2006).
Figure 4. mGlu5 receptor activity in the nucleus accumbens core, but not the dorsomedial caudate–putamen, is required for expression of the interoceptive effects of alcohol (1 g/kg, i.g.). a,
Targeted antagonism of mGlu5 receptors in the nucleus accumbens core reduced the discriminative stimulus effects of alcohol (1 g/kg; n  8), with no effect on response rate. * ,†p  0.03,
significant difference from 0 and 10 g of MPEP, respectively (Tukey’s test). b, Antagonism of mGlu5 receptors in the dorsomedial caudate–putamen did not alter the discriminative stimulus effects
of alcohol (n  8) or response rate. Illustrations (right side of each graph) depicting nucleus accumbens (core; a) and caudate–putamen (dorsomedial; b); circles illustrate injector placements from
individual rats with accurate placements and a corresponding photomicrograph showing an injector tract (arrow). c, The nucleus accumbens [Acb (core)] and dorsomedial caudate–putamen [CPu
(DM); n  5] showed similar mGlu5 receptor IR. Photomicrographs (100 oil) showing similar cytological expression of mGlu5 receptors in the nucleus accumbens and the dorsomedial
caudate–putamen. Arrows identify areas of dense mGlu5 receptor immunoreactivity. Scale bars, 25 m. d, Western blot analysis confirmed similar mGlu5 receptor expression in the nucleus
accumbens and the dorsomedial caudate–putamen (n  4). To the right of the graph is a coronal section of a rat brain showing location of bilateral tissue punches for Western blot analysis and a
representative Western blot (n  2) showing similar levels of mGlu5 receptors in the two brain regions. Green and blue bars represent the nucleus accumbens and the caudate, respectively. Values
on graphs represent mean  SEM.
9588 • J. Neurosci., July 29, 2009 • 29(30):9582–9591 Besheer et al. • Interoceptive Effects of Alcohol and mGlu5 Receptors
The present findings are the first to show that systemic antag-
onism of mGlu1 receptors does not produce alcohol-like intero-
ceptive effects and do not alter the interoceptive effects produced
by alcohol. That is, the reported reductions in alcohol self-
administration after similar manipulation of this receptor system
(Lominac et al., 2006; Besheer et al., 2008a,b) most likely are not
a result of an alteration to the interoceptive effects of the con-
sumed alcohol. Although the two group I mGlu receptors
(mGlu1 and mGlu5) are both located primarily at postsynaptic
sites, and share G-protein and cell signaling mechanisms (Gereau
and Conn, 1995; Shigemoto et al., 1997), there are important
differences between these receptors that may explain the func-
tional dissociation observed in the present study. That is, mGlu5
receptors are highly expressed in the nucleus accumbens (Ferra-
guti and Shigemoto, 2006), a brain region known to regulate the
discriminative stimulus effects of alcohol (Hodge and Cox, 1998;
Hodge et al., 2001a; Besheer et al., 2003). In contrast, mGlu1
receptors are densely expressed in the cerebellum (Shigemoto et
al., 1992; Fotuhi et al., 1993), in which they have been shown to
regulate motor activity and coordination
(Ichise et al., 2000). Indeed, motor inhibi-
tion (as indicated by decreased response
rate) was evident when the antagonist was
administered alone and in conjunction with
alcohol, consistent with previous findings of
motor impairments after mGlu1 receptor
antagonism (Steckler et al., 2005; Besheer et
al., 2008a,b). Thus, the functional dissocia-
tion between mGlu1 and mGlu5 receptors
in the interoceptive effects of alcohol may be
related to brain regional receptor expression
patterns and the role of these brain regions
in complex behavioral processes.
Given the importance of the striatal
circuitry in drug reward processes (Hy-
man et al., 2006) and the determined in-
volvement of mGlu5 receptors, but not
mGlu1 receptors, in the modulation of
the interoceptive effects of alcohol, we hy-
pothesized that striatal mGlu5 receptors
might regulate the interoceptive effects of
alcohol. The nucleus accumbens core was
identified as a potential target given that
this region showed significant inhibition
in neural activity after mGlu5 receptor an-
tagonism as indexed by quantification of
c-Fos immunoreactivity. To our knowl-
edge, this is the first study to show a sig-
nificant inhibition of neural activity in
the nucleus accumbens core after
mGlu5 receptor antagonism. Results
showed that site-specific pharmacologi-
cal inhibition of mGlu5 receptors in the
nucleus accumbens core blocked the
discriminative stimulus effects of sys-
temically administered alcohol, indicat-
ing that intra-accumbens mGlu5 recep-
tor activity is necessary for the full
expression of the interoceptive effects of
alcohol. Anatomical specificity of func-
tion was confirmed by the lack of effect of
mGlu5 receptor antagonism in the dorso-
medial caudate–putamen and the similar
cytological expression patterns and relative density of mGlu5 re-
ceptors between the brain regions. Although the dorsomedial
caudate is known to regulate stimulus–response relations
(Ragozzino, 2007; Tanaka et al., 2008; Balleine et al., 2009), such
as those required by the present procedure, the finding that an-
tagonism of mGlu5 receptors in this region did not alter accuracy
performance suggests that mGlu5 receptors within the dorsome-
dial caudate do not modulate drug-related interoceptive stimulus
properties. Indeed, future work will be needed to address this
possibility.
Importantly, functional involvement of intra-accumbens
mGlu5 receptors in the discriminative stimulus effects of alcohol
was further confirmed because activation of mGlu5 receptors in
this region enhanced the discriminative stimulus effects of a low
alcohol dose (0.5 g/kg), which indicates that activity of this recep-
tor system in the nucleus accumbens is sufficient to enhance the
interoceptive effects of a subthreshold alcohol dose. Further-
more, this enhancement produced by mGlu5 receptor activation
was blocked by intra-accumbens mGlu5 receptor antagonism.
Figure 5. Activation of mGlu5 receptors in the nucleus accumbens core potentiates the interoceptive effects of alcohol.
a, Targeted activation of mGlu5 receptors in the nucleus accumbens core by CHPG (10 g/side) enhanced the discrimina-
tive stimulus effects of alcohol (0.5 g/kg, i.g.). This enhancement was prevented by intra-accumbens inhibition of mGlu5
receptors with MPEP (20 g/side; n  8), with no effect on response rate (b). *p  0.05, significant difference from 0;
†p  0.05, significant difference from 10 g of CHPG (Tukey’s test). Circles illustrate nucleus accumbens (core) injector
placements from individual rats with accurate placements (c) and a corresponding photomicrograph showing an injector
tract (d; arrow). Values on graphs represent mean  SEM.
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These data indicate that mGlu5 receptor activity in the nucleus
accumbens is both necessary and sufficient for the full expression
of the interoceptive effects of alcohol.
The discriminative stimulus effects of alcohol comprise dis-
tinct components modulated by different receptor systems. In
general, the discriminative stimulus effects of lower doses of al-
cohol (1 g/kg) appear to be mediated by activation of inhibitory
GABAA receptors, whereas inhibition of excitatory NMDA re-
ceptors mediates the discriminative stimulus effects of higher
doses of alcohol (2 g/kg) (Grant and Colombo, 1993; Grant,
1999). Given that intra-accumbens antagonism of mGlu5 recep-
tors inhibited the discriminative stimulus effects of a lower dose
of alcohol (1 g/kg) and activation of mGlu5 receptors enhanced
the discriminative stimulus effects of a low alcohol dose (0.5
g/kg), we hypothesize that mGlu5 modulation of the interocep-
tive effects of alcohol in this brain region may occur through an
interaction with the GABAergic component of the alcohol intero-
ceptive cue. This hypothesis is supported in part by evidence
showing that GABAA-positive modulators (i.e., pentobarbital,
muscimol) administered into the nucleus accumbens produce
alcohol-like properties in animals trained with 1 g/kg alcohol
(Hodge and Cox, 1998; Hodge et al., 2001a; Besheer et al., 2003).
Furthermore, there is evidence for interaction between mGlu5
receptors and GABA systems, because intra-accumbens infusion
of the mGlu5 receptor agonist CHPG increases GABA release in
the ventral pallidum, an effect that is reversed by the mGlu5
receptor antagonist MPEP (Díaz-Cabiale et al., 2002). Also, per-
fusion of CHPG into the periaquaductal gray has been shown to
enhance extracellular levels of GABA in that region; again, an
effect that is reversed by MPEP (de Novellis et al., 2003). Further-
more, anatomical evidence indicates that both GABAA and
GABAB receptors are coexpressed with mGlu5 receptors in the
striataopallidal complex (Smith et al., 2000) and that this ana-
tomical distribution may regulate an interaction between mGlu5
and GABA receptors in alcohol discrimination (Besheer et al.,
2005). Moreover, it is unlikely that the mGlu5 receptor antago-
nist effects observed in this study were mediated through NMDA
receptors because MPEP has been shown to inhibit NMDA re-
ceptor function (O’Leary et al., 2000), which should enhance
(Grant and Colombo, 1993; Grant, 1999) rather than inhibit the
discriminative stimulus effects of alcohol. Similarly, the CHPG-
induced enhancement of the discriminative stimulus effects of
alcohol is not likely mediated through NMDA receptors because
CHPG has been shown to potentiate NMDA receptor function
(Doherty et al., 1997), an effect that would not be predicted to
enhance the discriminative stimulus effects of alcohol. However,
we predict that a potential interaction between mGlu5 and
NMDA receptor systems in modulating the interoceptive effects
of alcohol would be more likely with a higher alcohol training
dose (i.e., 2 g/kg). Clearly, establishing whether intra-accumbens
mGlu5 receptor involvement in the interoceptive effects of alco-
hol is interacting with the GABAergic or NMDA receptor com-
ponent will need to be directly assessed in future work.
In conclusion, considerable progress has been made in under-
standing how mesocorticolimbic systems regulate the motivation
to seek natural rewards and addictive drugs (Schultz, 2000; Hy-
man et al., 2006). Our findings indicate that mGlu5 receptor
activity in the nucleus accumbens, a central component of the
reward circuitry of the brain, also plays a critical role in the per-
ception of alcohol. Although the specific role of interoceptive
drug effects in the contribution to drug use is unknown, there
exist several possibilities by which the interoceptive effects may
influence drug-seeking and self-administration behavior. For ex-
ample, it is possible that the interoceptive cues that accompany
drug self-administration come to function as conditioned stimuli
that may promote drug-seeking (Wise et al., 2008). In addition,
the ability to perceive the characteristic interoceptive properties
of a drug may encourage drug-seeking by indicating the effects of
sampled substances and, consequently, directing the individual
toward one substance rather than another (Stolerman, 1992).
Within this framework, the results of the present work suggest
that mGlu5 receptors may regulate alcohol self-administration
(Bäckström et al., 2004; Cowen et al., 2005; Schroeder et al., 2005;
Hodge et al., 2006; Lominac et al., 2006; Cowen et al., 2007;
Besheer et al., 2008b) by integrating information about the in-
teroceptive and reinforcing effects of alcohol.
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